Germany
Japan
United Kingdom
China
KCNJ16 (myc-DDK-tagged) - Human potassium inwardly-rectifying channel, subfamily J, member 16 (KCNJ16), transcript variant 8
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Expression Plasmids
DownloadSSTR3 (myc-DDK-tagged) - Human somatostatin receptor 3 (SSTR3), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
MXRA8 (myc-DDK-tagged) - Human matrix-remodelling associated 8 (MXRA8), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC29A2 (myc-DDK-tagged) - Human solute carrier family 29 (equilibrative nucleoside transporter), member 2 (SLC29A2), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ENPP5 (myc-DDK-tagged) - Human ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) (ENPP5), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC38A1 (myc-DDK-tagged) - Human solute carrier family 38, member 1 (SLC38A1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC38A1 (myc-DDK-tagged) - Human solute carrier family 38, member 1 (SLC38A1), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC38A1 (myc-DDK-tagged) - Human solute carrier family 38, member 1 (SLC38A1), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
PLD3 (myc-DDK-tagged) - Human phospholipase D family, member 3 (PLD3), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
KCNS3 (myc-DDK-tagged) - Human potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 (KCNS3), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC43A3 (myc-DDK-tagged) - Human solute carrier family 43, member 3 (SLC43A3), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
OPRM1 (myc-DDK-tagged) - Human opioid receptor, mu 1 (OPRM1), transcript variant MOR-1CA
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
VRK2 (myc-DDK-tagged) - Human vaccinia related kinase 2 (VRK2), transcript variant 8
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
USD 420.00
In Stock
ACVR2A (myc-DDK-tagged) - Human activin A receptor, type IIA (ACVR2A), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC2A14 (myc-DDK-tagged) - Human solute carrier family 2 (facilitated glucose transporter), member 14 (SLC2A14), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CATSPER2 (myc-DDK-tagged) - Human cation channel, sperm associated 2 (CATSPER2), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
PTPN5 (myc-DDK-tagged) - Human protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) (PTPN5), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ITFG3 (myc-DDK-tagged) - Human integrin alpha FG-GAP repeat containing 3 (ITFG3), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ERMARD (myc-DDK-tagged) - Human ER membrane-associated RNA degradation (ERMARD), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
GGT1 (myc-DDK-tagged) - Human gamma-glutamyltransferase 1 (GGT1), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
C17orf80 (myc-DDK-tagged) - Human chromosome 17 open reading frame 80 (C17orf80), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
LRRTM4 (myc-DDK-tagged) - Human leucine rich repeat transmembrane neuronal 4 (LRRTM4), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC26A7 (myc-DDK-tagged) - Human solute carrier family 26 (anion exchanger), member 7 (SLC26A7), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLITRK1 (myc-DDK-tagged) - Human SLIT and NTRK-like family, member 1 (SLITRK1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TMEM168 (myc-DDK-tagged) - Human transmembrane protein 168 (TMEM168), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ACSL1 (myc-DDK-tagged) - Human acyl-CoA synthetase long-chain family member 1 (ACSL1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
STT3A (myc-DDK-tagged) - Human STT3A, subunit of the oligosaccharyltransferase complex (catalytic) (STT3A), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
GYLTL1B (myc-DDK-tagged) - Human glycosyltransferase-like 1B (GYLTL1B), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SEMA3B (myc-DDK-tagged) - Human sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B (SEMA3B), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CDH18 (myc-DDK-tagged) - Human cadherin 18, type 2 (CDH18), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
NLGN4X (myc-DDK-tagged) - Human neuroligin 4, X-linked (NLGN4X), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
NLGN4X (myc-DDK-tagged) - Human neuroligin 4, X-linked (NLGN4X), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ADAM29 (myc-DDK-tagged) - Human ADAM metallopeptidase domain 29 (ADAM29), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ADAM29 (myc-DDK-tagged) - Human ADAM metallopeptidase domain 29 (ADAM29), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ADAM29 (myc-DDK-tagged) - Human ADAM metallopeptidase domain 29 (ADAM29), transcript variant 7
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
RNF19A (myc-DDK-tagged) - Human ring finger protein 19A, RBR E3 ubiquitin protein ligase (RNF19A), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
DDR1 (myc-DDK-tagged) - Human discoidin domain receptor tyrosine kinase 1 (DDR1), transcript variant 7
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
DDR1 (myc-DDK-tagged) - Human discoidin domain receptor tyrosine kinase 1 (DDR1), transcript variant 8
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
USD 750.00
In Stock
GRM1 (myc-DDK-tagged) - Human glutamate receptor, metabotropic 1 (GRM1), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
USD 750.00
In Stock
GRM1 (myc-DDK-tagged) - Human glutamate receptor, metabotropic 1 (GRM1), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
NFXL1 (myc-DDK-tagged) - Human nuclear transcription factor, X-box binding-like 1 (NFXL1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
NFXL1 (myc-DDK-tagged) - Human nuclear transcription factor, X-box binding-like 1 (NFXL1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
DDR1 (myc-DDK-tagged) - Human discoidin domain receptor tyrosine kinase 1 (DDR1), transcript variant 9
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
KCNT2 (myc-DDK-tagged) - Human potassium channel, subfamily T, member 2 (KCNT2), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
L1CAM (myc-DDK-tagged) - Human L1 cell adhesion molecule (L1CAM), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BAI2 (myc-DDK-tagged) - Human brain-specific angiogenesis inhibitor 2 (BAI2), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ADCY1 (myc-DDK-tagged) - Human adenylate cyclase 1 (brain) (ADCY1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TRPV1 (Myc-DDK-tagged)-Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Active filters
Category
- cDNA Clones
Tags
- Myc-DDK
Mammalian Cell Selection
- Neomycin
Families
- Transmembrane
Availabilities
- In Stock
Filter by
Target Symbol
- BDNF (17)
- OPRM1 (17)
- NRG1 (14)
- DAG1 (13)
- MYADM (12)
- CD46 (10)
- P2RY6 (9)
- ADGRG1 (8)
- ASPH (8)
- CD44 (8)
- CHRM2 (8)
- GHR (8)
- KCNE1 (8)
- KCNJ15 (8)
- PTGER3 (8)
- SLITRK2 (8)
- ADAM29 (7)
- CD1E (7)
- CLEC4M (7)
- CSF2RA (7)
- FGFR1 (7)
- GABRA1 (7)
- HMOX2 (7)
- SIGLEC10 (7)
- TMEM9 (7)
- TP53I11 (7)
- TSPAN4 (7)
- ZFYVE27 (7)
- APP (6)
- B3GALT5 (6)
- CLDND1 (6)
- CPT1B (6)
- DDR1 (6)
- GPR1 (6)
- HHAT (6)
- HTR4 (6)
- IFI27 (6)
- IL1RAP (6)
- IL5RA (6)
- KCNJ16 (6)
- LDLR (6)
- LDLRAD4 (6)
- NIPA2 (6)
- SIGLEC6 (6)
- SLC16A3 (6)
- ST3GAL3 (6)
- TMEM139 (6)
- VRK2 (6)
- YIF1B (6)
- ABCG1 (5)
- ACBD4 (5)
- ADIPOR1 (5)
- ADORA2A (5)
- AGTR1 (5)
- ASGR2 (5)
- B3GALNT1 (5)
- BLCAP (5)
- CD36 (5)
- CD8B (5)
- CEACAM1 (5)
- CLDN14 (5)
- CNR1 (5)
- ENTPD1 (5)
- FCGR2B (5)
- FXYD6 (5)
- GCNT1 (5)
- GGT1 (5)
- GHRL (5)
- GLT8D1 (5)
- ICAM2 (5)
- KCNJ1 (5)
- KCNMB3 (5)
- MDK (5)
- MFSD11 (5)
- MGAT1 (5)
- MGST1 (5)
- MUC1 (5)
- NTRK2 (5)
- P2RX2 (5)
- PMP22 (5)
- PRNP (5)
- PTPRO (5)
- RNASE4 (5)
- RTN4 (5)
- SLC11A2 (5)
- SLC29A1 (5)
- SLC30A8 (5)
- SLC37A4 (5)
- SLC38A1 (5)
- SLC39A1 (5)
- SPAM1 (5)
- STEAP2 (5)
- STRA6 (5)
- TEX264 (5)
- TMEM218 (5)
- ZDHHC16 (5)
- ABCB5 (4)
- ADRA1A (4)
- APLP2 (4)
- APOL1 (4)
Species
Mutants
Pathways
- Metabolic pathways (461)
- Neuroactive ligand-receptor interaction (407)
- Olfactory transduction (337)
- Cytokine-cytokine receptor interaction (269)
- Cell adhesion molecules (CAMs) (198)
- Calcium signaling pathway (190)
- Hematopoietic cell lineage (141)
- Pathways in cancer (124)
- MAPK signaling pathway (113)
- Jak-STAT signaling pathway (89)
- Dilated cardiomyopathy (81)
- Natural killer cell mediated cytotoxicity (81)
- Alzheimer's disease (80)
- Antigen processing and presentation (76)
- Regulation of actin cytoskeleton (73)
- ECM-receptor interaction (70)
- Vascular smooth muscle contraction (70)
- Hypertrophic cardiomyopathy (HCM) (68)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (67)
- Chemokine signaling pathway (67)
- Endocytosis (67)
- Lysosome (64)
- Axon guidance (63)
- N-Glycan biosynthesis (63)
- Viral myocarditis (62)
- Huntington's disease (61)
- ABC transporters (60)
- Leukocyte transendothelial migration (58)
- Focal adhesion (54)
- Oxidative phosphorylation (52)
- Melanogenesis (50)
- Drug metabolism - cytochrome P450 (49)
- Graft-versus-host disease (47)
- Retinol metabolism (46)
- Adipocytokine signaling pathway (45)
- Parkinson's disease (45)
- Systemic lupus erythematosus (45)
- SNARE interactions in vesicular transport (44)
- Adherens junction (43)
- Cardiac muscle contraction (43)
- PPAR signaling pathway (43)
- Autoimmune thyroid disease (42)
- Purine metabolism (42)
- Glycerophospholipid metabolism (41)
- Neurotrophin signaling pathway (41)
- Taste transduction (41)
- Glycosphingolipid biosynthesis - lacto and neolacto series (40)
- Metabolism of xenobiotics by cytochrome P450 (40)
- Colorectal cancer (39)
- Allograft rejection (38)
- Gap junction (38)
- Tight junction (38)
- Type I diabetes mellitus (38)
- O-Glycan biosynthesis (37)
- Apoptosis (36)
- ErbB signaling pathway (36)
- Wnt signaling pathway (36)
- GnRH signaling pathway (34)
- Sphingolipid metabolism (33)
- Toll-like receptor signaling pathway (32)
- Androgen and estrogen metabolism (31)
- Drug metabolism - other enzymes (31)
- Primary immunodeficiency (31)
- Vibrio cholerae infection (31)
- Arachidonic acid metabolism (30)
- Basal cell carcinoma (30)
- Epithelial cell signaling in Helicobacter pylori infection (30)
- Porphyrin and chlorophyll metabolism (30)
- Amyotrophic lateral sclerosis (ALS) (29)
- Long-term depression (29)
- Starch and sucrose metabolism (29)
- T cell receptor signaling pathway (29)
- Asthma (28)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (28)
- TGF-beta signaling pathway (28)
- Ether lipid metabolism (27)
- Complement and coagulation cascades (26)
- Fatty acid metabolism (26)
- Heparan sulfate biosynthesis (26)
- Keratan sulfate biosynthesis (26)
- Prostate cancer (26)
- Chondroitin sulfate biosynthesis (25)
- Fc gamma R-mediated phagocytosis (25)
- Long-term potentiation (25)
- Melanoma (24)
- Pancreatic cancer (23)
- B cell receptor signaling pathway (22)
- Glutathione metabolism (22)
- Glycerolipid metabolism (22)
- Glycosphingolipid biosynthesis - globo series (22)
- Notch signaling pathway (21)
- Pyrimidine metabolism (21)
- Type II diabetes mellitus (21)
- Ascorbate and aldarate metabolism (20)
- Hedgehog signaling pathway (20)
- Linoleic acid metabolism (19)
- Pentose and glucuronate interconversions (19)
- p53 signaling pathway (19)
- Glycosphingolipid biosynthesis - ganglio series (18)
- Renin-angiotensin system (17)
- Tyrosine metabolism (17)
- Fc epsilon RI signaling pathway (16)
- Progesterone-mediated oocyte maturation (16)
- Oocyte meiosis (15)
- Small cell lung cancer (15)
- Steroid biosynthesis (15)
- Biosynthesis of unsaturated fatty acids (14)
- Chronic myeloid leukemia (14)
- Prion diseases (14)
- Riboflavin metabolism (12)
- Bladder cancer (11)
- Insulin signaling pathway (11)
- Pathogenic Escherichia coli infection (11)
- Renal cell carcinoma (11)
- Cytosolic DNA-sensing pathway (10)
- Galactose metabolism (10)
- Glycosaminoglycan degradation (10)
- Nicotinate and nicotinamide metabolism (10)
- Cyanoamino acid metabolism (9)
- Glioma (9)
- Non-small cell lung cancer (9)
- Selenoamino acid metabolism (9)
- Taurine and hypotaurine metabolism (9)
- Ubiquitin mediated proteolysis (9)
- Endometrial cancer (8)
- Phosphatidylinositol signaling system (8)
- RIG-I-like receptor signaling pathway (8)
- VEGF signaling pathway (8)
- alpha-Linolenic acid metabolism (8)
- Primary bile acid biosynthesis (7)
- C21-Steroid hormone metabolism (6)
- Caffeine metabolism (6)
- Nitrogen metabolism (6)
- Phenylalanine metabolism (6)
- Sulfur metabolism (6)
- Thyroid cancer (6)
- Tryptophan metabolism (6)
- Glycine (5)
- Inositol phosphate metabolism (5)
- beta-Alanine metabolism (5)
- serine and threonine metabolism (5)
- Acute myeloid leukemia (4)
- Amino sugar and nucleotide sugar metabolism (4)
- Dorso-ventral axis formation (4)
- Glycolysis / Gluconeogenesis (4)
- Limonene and pinene degradation (4)
- NOD-like receptor signaling pathway (4)
- Propanoate metabolism (4)
- Arginine and proline metabolism (3)
- Cell cycle (3)
- Histidine metabolism (3)
- Lysine degradation (3)
- O-Mannosyl glycan biosynthesis (3)
- Protein export (3)
- Pyruvate metabolism (3)
- Valine (3)
- leucine and isoleucine degradation (3)
- Butanoate metabolism (2)
- Fatty acid elongation in mitochondria (2)
- Other glycan degradation (2)
- Pantothenate and CoA biosynthesis (2)
- Base excision repair (1)
- Citrate cycle (TCA cycle) (1)
- Fatty acid biosynthesis (1)
- Maturity onset diabetes of the young (1)
- Terpenoid backbone biosynthesis (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)